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Introduction
Pelviureteric junction obstruction (PUJO) refers to impair-
ment of the normal transport of urine from the renal pelvis 
to the ureter.1 The pelviureteric junction (PUJ) is the most 
common site of obstruction along the upper urinary tract,2,3 
and PUJO is the most common cause of hydronephrosis in 
children.4 Inadequate drainage of urine from the renal pelvis 
into the ureter results in hydrostatic distension of the renal 
pelvis and intrarenal calyces. The combination of raised in-
trapelvic pressure and stasis of urine in the collecting ducts 
results in progressive kidney damage and deterioration of 
renal function.5 Most cases are congenital in origin and are 
diagnosed prenatally in most developed countries.6 Inade-
quate canalization of the pelviureteric area, the premature 
arrest of ureteral muscular development, and a deficiency of 
interstitial cells of Cajal have been proposed as embryologic 
bases for this anomaly.7,8 Other possible causes include uret-
eral atresia, polyps, valves, extrinsic compression by aberrant 
early-branching lower pole vessels, retroperitoneal fibrosis, 
tumours, and ureteral stones.6,9,10
PUJO treatment has evolved from the open techniques 
to minimally invasive (endoscopic and laparoscopic) tech-
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Results
The age range of the 32 included PUJO patients was 2–60 years, with a median age of 30 years. Children constituted 31% of 
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had normal renal function at the time of surgery, and Anderson–Hynes pyeloplasty was the most common technique employed 
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Conclusions
Most patients with PUJO presented late. Most of our patients underwent Anderson–Hynes pyeloplasty with satisfactory outcomes.
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niques. The main techniques commonly employed in our 
environment are the Anderson–Hynes dismembered py-
eloplasty and the Foley Y-V plasty.11–13 
This article describes our experience with the manage-
ment of PUJO at a Nigerian teaching hospital.
Methods
We reviewed the records of patients treated for PUJO  from 
January 2005 to December 2014 at our centre. Clinical in-
formation was obtained from the medical records, theatre 
records, and ward registers. Data extracted included demo-
graphic characteristics, clinical presentation, and duration 
of symptoms. We also extracted results of relevant investiga-
tions, such as full blood count; electrolytes, urea, and creati-
nine; and urine microscopy, culture, and sensitivity. Informa-
tion on abdominopelvic ultrasound, intravenous urography 
(IVU), computed tomography (CT) urogram, retrograde 
pyelogram, and treatment options were also retrieved. Pa-
tients were operated upon under general anaesthesia. Post-
operative complications were documented. Serum electro-
lyte, urea, and creatinine measurements were repeated after 
surgery. Abdominopelvic ultrasound was carried out 4–6 
weeks after surgery to assess and compare the degree of re-
nal and the upper urinary tract dilatation. Double J stents 
were removed within 4–6 weeks after surgery. Patients were 
followed up for a period of 6 months to 2 years. Any record 
of persistent postoperative pain was identified from the case 
notes. For this study, children ≤ 6 years of age were regarded 
as young children. We defined renal impairment as serum 
creatinine greater than132 µmol/L. Data obtained were anal-
ysed using SPSS version 20 (IBM Corp., Armonk, NY, USA) 
and results were expressed as means and percentages. 
Results
Of the 42 patients that were surgically treated for PUJO at 
our centre during the study period, 32 records (76%) were 
available for review. Patient age ranged from 2 to 60 years, 
with a mean age of 28 ± 17 years and a median age of 30 
years. The age distribution of patients is shown in Figure 
1. There were 10 patients (31%) younger than 15 years of 
age. Fifteen patients were male, and the male-to-female ra-
tio was 0.88:1. Most of the children (n = 6; 60%), especial-
ly the younger ones, presented with an abdominal mass or 
abdominal swelling. One patient was asymptomatic, while 
symptom duration ranged from 1 month to 10 years in the 
symptomatic ones, with a mean duration of 2 years. The ob-
struction was on the left in 19 patients (59%), on the right in 
9 patients (28%), and bilateral in 4 patients (13%).
Loin pain was the commonest symptom (n = 26; 81%), 
while recurrent fever and loin swelling were found in 10 
(31%) and 8 patients (25%), respectively. The symptom pro-
file was as shown in Table 1. All patients had normal blood 
urea and serum creatinine preoperatively; 1 patient had leu-
kocytosis. Eight patients (25%) had a positive preoperative 
urine culture featuring gram-negative organisms (3 Klebsiel-
la, 3 Escherichia coli, and 2 Pseudomonas). One patient (3%) 
had concomitant nephrolithiasis.
All patients underwent abdominal ultrasound scanning, 
which showed hydronephrosis, marked pelvicalyceal dilata-
tion, and sometimes cortical thinning in the ipsilateral kid-
neys. IVU was conducted on 25 patients (78%). IVU findings 
Figure 1.  Patient age distribution
Table 1. Preoperative symptoms
Symptom n (%)
Loin pain 26 (81)
Recurrent fever 10 (31)
Nausea/vomiting 6 (19)
Loin swelling/mass 8 (25)
Haematuria 1 (3)
Failure to thrive 1 (3)
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included enlarged hydronephrotic kidneys with pelvicalyceal 
dilatation, sharp indentation or a sharp cutoff of contrast at 
the PUJ, inability to identify the ureter, delayed contrast ex-
cretion, and non-excreting kidney. Six patients (19%) who 
had non-excreting kidneys on IVU underwent retrograde 
ureteropyelography. CT urography was conducted on 5 pa-
tients (16%), all of whom were adults being investigated for 
suspected malignancy. 
The intraoperative aetiologic findings are shown 
in Table 2. All patients received either a double J stent 
(n = 26; 81%) or a modified Cumming’s catheter (n = 6; 19%) 
for postoperative stenting. Hospital stay ranged from 5 to 31 
days (median = 11 days). There was no mortality. 
Postoperative complications were seen in 6 patients (19%) 
(Table 3). All patients had good postoperative renal function. 
During follow-up, symptom resolution was achieved for 31 
patients (97%); 1 patient (3%) had persistent loin pain.
Discussion
The diagnosis of PUJO is made mostly in the third and 
fourth decades of life in most tertiary hospitals in Nigeria1,2,14 
and other developing countries,15,16 as was seen in our study, 
which had a mean patient age of 30 years. In developed 
countries, almost all abnormalities of the PUJ are detected 
and treated early in life due to the widespread use of pre-
natal ultrasound and the advent of modern imaging tech-
niques.17–19 None of the patients in our study were diagnosed 
prenatally even though ultrasound is readily available and 
the cost of prenatal ultrasound screening is relatively low. It 
is, therefore, not surprising that 31% of the patients in our 
study presented during childhood, even though this age of 
presentation is late compared to what is seen in developed 
countries.18,19 It appears that prenatal diagnosis will continue 
to elude most patients in developing countries until prenatal 
screening is incorporated into national healthcare policies.
In contrast to most studies,1,15,20 where a higher incidence 
of PUJO was reported in males, our series had a slight female 
preponderance. This finding is, however, similar to findings 
from elsewhere,21–23 the explanation for the sex difference is 
unknown. PUJO has previously been reported to predomi-
nate on the left, and bilateral obstruction has been reported 
in 10%–40% of patients17,24; this also agrees with our find-
ings. 
In this study, as with other reports,3,16 the presenting 
complaints depended on patient age. We noted that young 
children tended to present with asymptomatic abdominal 
masses, while the older children and adults more commonly 
presented with loin pain. The most common symptom in our 
study was flank pain, and this concurs with other reports.1,2,21 
The diagnosis of PUJO is confirmed principally by renal 
ultrasound, IVU, CT or magnetic resonance urography, di-
uretic isotope renogram, or retrograde ureteropyelography. 
In our study as well as in other published articles from devel-
oping countries,1,3,15 renal ultrasonography, IVU, retrograde 
ureteropyelography, and CT urography have been found 
valuable in assessing the degree of hydronephrosis, differen-
tial renal function, and also in defining the anatomical ab-
normality at the PUJ. It is also worth noting that CT urogra-
phy was used to exclude renal malignancy in 3 patients in our 
study. The usefulness of renal isotope scanning in the diag-
nosis and management of PUJO cannot be overemphasized, 
as it allows for the determination of renal perfusion, differ-
ential renal function of each kidney, and the rate at which 
isotope leaves the renal pelvis. The differential renal function 
is said to be significant when it is < 40%.3,17 This percentage 
has been shown to correlate with the half-life washout curve. 
Mughal and colleagues3 observed that if renal isotope scan-
ning shows PUJO in a kidney and the split renal function is 
15–40%, pyeloplasty should be performed.3 However, where 
the relative renal function is less than 20%, it is better to give 
such kidneys a chance to recover after temporary relief of 
the obstruction with a percutaneous nephrostomy. Renal 
isotope scanning was not available at our facility during the 
study period, and this is a limitation of this study.
The most common cause of PUJO in our series was ure-
teral narrowing at the PUJ, followed by extrinsic compres-
sion by an aberrant lower pole vessel, and this agrees with 
the findings from elsewhere.1,15 This aberrant vessel could be 
the lower branch of the main renal vessel. Lee et al. observed 
that in about 40% of PUJO, an aberrant, accessory or ear-
ly-branching lower pole vessel is found.17 This is much high-
er than the 25% observed in this study.
The goals of PUJO management are to improve urine 
Table 2. Intraoperative findings and procedures performed
Intraoperative aetiologic findings n (%)
Peri-ureteral adhesive bands 6 (19)
Lower pole aberrant vessels 8 (25)
Pelviureteric junction atresia 17 (53)
Multiple pathologies (adhesive 
band + lower pole vessel) 1 (3)
Procedure
Anderson–Hynes pyeloplasty 23 (72)
Foley Y-V pyeloplasty 5 (16)
Simple nephrectomy 3 (9)
Intubated ureterotomy +
nephrolithotomy 1 (3)
Table 3. Postoperative complications
Complication n (%)
Wound infection 3 (9)
Postoperative pyelonephritis 1 (3)
Sepsis and shunt malformation
(necessitating pyelostomy) 1 (3)
Incisional hernia 1 (3)
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flow, alleviate symptoms, and prevent further damage to 
the renal parenchyma, ultimately improving renal function. 
Open pyeloplasty is the comparative gold standard for PUJO 
treatment in children and adults, and Anderson–Hynes 
pyeloplasty is the most common method employed global-
ly.2,3 The overall success rate is said to be between 90% and 
100%.25,26 In our study, Anderson-Hynes dismembered py-
eloplasty was performed in two-thirds of patients, with an 
overall success rate that is similar to that reported by other 
studies.1,3,15 Foley Y-V plasty was performed in a few patients 
because they had grossly distended and redundant renal 
pelves.
The surgical management of PUJO has evolved from 
the traditional open pyeloplasty, to endopyelotomy in se-
lected patients, to laparoscopic pyeloplasty. More recently, 
robot-assisted laparoscopic pyeloplasty (RALP) (using the 
da Vinci Surgical System; Intuitive Surgical, Sunnyvale, CA, 
USA) has emerged as a minimally invasive treatment op-
tion for PUJO with several benefits over conventional lap-
aroscopic pyeloplasty. These minimally invasive techniques 
have several advantages over open pyeloplasty: quicker re-
covery, shorter hospital stay, and fewer postoperative analge-
sic requirements. The outcomes of these minimally invasive 
procedures have been shown to compare favourably to open 
pyeloplasty.11–13,26
Four postoperative complications of pyeloplasty were 
encountered in our study. These were wound infection, py-
elonephritis, shunt malfunction, and incisional hernia. One 
patient with wound infection was placed on parenteral an-
tibiotics and daily wound dressing. The only patient who 
had pyelonephritis subsequently yielded a urine culture 
that grew E. coli sensitive to cefuroxime. The patients with 
shunt malfunction and incisional hernia, respectively, un-
derwent shunt removal via cystoscopy and herniorrhaphy 11 
months after pyeloplasty. The various postoperative compli-
cations noted in this study compare favourably with those 
encountered in other studies.3,21 Abdominal ultrasonography 
repeated 4–6 weeks after surgery revealed significant relief 
of obstruction in all patients. In our series, the majority of 
the patients had satisfactory renal function and were symp-
tom-free postoperatively except for 1 patient who experi-
enced persistent pain. We found this to be in tandem with 
other reports.1,3,15
Conclusions
Most of our patients with PUJO  presented late. Prenatal ul-
trasound and a high index of suspicion are desirable for early 
detection and treatment. Anderson–Hynes open pyeloplasty 
remains our treatment of choice because of its effectiveness 
and associated low complication rate.
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